Matarin Capital Management’s Medpace MEDP Stock Holding History

Matarin Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$3.08M	Sell	22,096 -26,305	-54%	-$3.32M	0.75%	49
2020 Q3	$5.41M	Sell	48,401 -6,431	-12%	-$744K	1.13%	11
2020 Q2	$5.1M	Sell	54,832 -70,786	-56%	-$6.02M	1.02%	18
2020 Q1	$9.22M	Sell	125,618 -10,403	-8%	-$903K	1.43%	3
2019 Q4	$11.4M	Sell	136,021 -9,943	-7%	-$770K	1.09%	8
2019 Q3	$12.3M	Buy	145,964 +77,220	+112%	+$5.83M	0.93%	27
2019 Q2	$4.5M	Buy	68,744 +997	+1%	+$57.5K	0.32%	116
2019 Q1	$4M	Buy	+67,747	New	+$4.05M	0.29%	127

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Matarin Capital Management's MEDP Position: Q4 2020 in Review

Matarin Capital Management reduced its Medpace (MEDP) stake by 54% in Q4 2020, selling an estimated $3.32M and leaving 22,096 shares worth $3.08M. The position accounts for 0.75% of the portfolio, ranked #49.

Matarin Capital Management first reported a position in MEDP in Q1 2019 and has held it in 8 quarters since. The position peaked at $12.3M in Q3 2019. 316 funds tracked by Wall St. Rank hold MEDP as of Q4 2020.

Matarin Capital Management held 22,096 shares of Medpace worth $3.08M as of Q4 2020.
Matarin Capital Management sold 26,305 Medpace shares in Q4 2020, an estimated $3.32M.
Medpace made up 0.75% of Matarin Capital Management's portfolio in Q4 2020, its #49 holding.
Matarin Capital Management first reported a position in Medpace in Q1 2019 and has held it in 8 quarters since.
Matarin Capital Management's Medpace position peaked at $12.3M in Q3 2019.
316 funds tracked by Wall St. Rank held Medpace as of Q4 2020.

Based on Matarin Capital Management's 13F filing for Q4 2020, filed 3 Feb 2021.